Nanoparticles (NPs) are, in general, colloidal particles, less than 1000 nm, that can be used
for better drug delivery and prepared either by encapsulating the drug within a vesicle and …

Conventional drug delivery systems contain numerous limitations such as limited targeting,
low therapeutic indices, poor water solubility, and the induction of drug resistances. In order …

In recent decades, nanoparticulate drug delivery systems have attracted extensive attention
in cancer therapy for such appealing properties as small particle size, huge surface area …

The widespread development of nanocarriers to deliver chemotherapeutics to specific tumor
sites has been motivated by the lack of selective targeting during chemotherapy inducing …

Research into the application of nanocarriers in the delivery of cancer-fighting drugs has
been a promising research area for decades. On the other hand, their cytotoxic effects on …

Development of new delivery systems that deliver the potential drug specifically to the target
site in order to meet the therapeutic needs of the patients at the required time and level …

The use of nanoparticulate pharmaceutical drug delivery systems (NDDSs) to enhance the
in vivo effectiveness of drugs is now well established. The development of multifunctional …

The blood–brain barrier (BBB) represents an insurmountable obstacle for a large number of
drugs, including antibiotics, antineoplastic agents, and a variety of central nervous system …

Chemotherapeutic treatment with conventional drug formulations pose numerous
challenges, such as poor solubility, high cytotoxicity and serious off‐target side effects, low …

Nanotechnology deals with the design, production, characterization and application of sub-
micron-sized particles. The popularity and effectiveness of small-sized particles can be …